Kestra Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.24M | Buy |
|
|||||
|
2025
Q2 | $708K | Sell |
|
|||||
|
2025
Q1 | $559K | Buy |
|
|||||
|
2024
Q4 | $630K | Buy |
|
|||||
|
2024
Q3 | $572K | Sell |
|
|||||
|
2024
Q2 | $870K | Buy |
|
|||||
|
2024
Q1 | $1.07M | Buy |
|
|||||
|
2023
Q4 | $713K | Buy |
|
|||||
|
2023
Q3 | $255K | Sell |
|
|||||
|
2023
Q2 | $342K | Buy |
|
|||||
|
2023
Q1 | $272K | Sell |
|
|||||
|
2022
Q4 | $255K | Sell |
|
|||||
|
2022
Q3 | $440K | Sell |
|
|||||
|
2022
Q2 | $415K | Buy |
|
|||||
|
2022
Q1 | $340K | Buy |
|
|||||
|
2021
Q4 | $326K | Sell |
|
|||||
|
2021
Q3 | $1.4M | Buy |
|
|||||
|
2021
Q2 | $1.98M | Buy |
|
|||||
|
2021
Q1 | $729K | Sell |
|
|||||
|
2020
Q4 | $1.74M | Buy |
|